声触诊弹性成像检测肝脾硬度诊断慢性乙型肝炎患者肝纤维化效能分析*

doi:10.3969/j.issn.1672-5069.2022.02.008

摘要/Abstract

摘要： 目的探讨应用声触诊弹性成像(APE)行肝脏硬度检测(LSM)和脾脏硬度检测(SSM)诊断慢性乙型肝炎(CHB)患者肝纤维化的效能。方法 2020年1月～2021年10月我院诊治的CHB患者392例,行肝穿刺组织病理学检查,将≤F1期为非显著性肝纤维化,≥F2期为显著性肝纤维化,F4期为早期肝硬化。使用超声APE计数获得LSM和SSM。计算天冬氨酸氨基转移酶/血小板比值(APRI)、基于4因子指数(FIB-4)和King's 指数。应用受试者工作特征曲线下面积(AUC)评估各项指标诊断肝纤维化的效能。结果在392例CHB患者中,组织病理学检查发现F0期45例、F1期112例、F2期105例、F3期70例和F4期60例,即非显著肝纤维化157例,显著肝纤维化235例;显著肝纤维化患者LSM、SSM、APRI、FIB-4和King's score分别为(13.4±2.0)kPa、(23.3±4.0)kPa、(2.2±0.4)、(1.8±0.4)和(23.4±7.9)分,显著大于非显著性肝纤维化组[【分别为(9.3±1.7)kPa、(15.0±3.6)kPa、(1.0±0.2)、(0.9±0.2)和(10.4±6.9)分,P<0.05】;多因素Logistic回归分析显示,LSM、SSM、APRI、FIB-4和King's score均是影响肝纤维化发生的独立因素(P<0.05);LSM联合SSM诊断显著性肝纤维化的敏感度、特异度和准确度分别为79.6%、83.0%和81.6%,诊断早期肝硬化的敏感度、特异度和准确度分别为92.8%、90.0%和92.3%。结论应用APE检测CHB患者LSM和SSM可有效评价肝纤维化程度,作为无创诊断手段,值得进一步研究。

关键词: 慢性乙型肝炎, 肝纤维化, 声触诊弹性成像, 肝脏硬度检测, 脾脏硬度检测, 诊断

Abstract: Objective The aim of this study was to investigate the noninvasive assessment of liver fibrosis (LF) via liver (LSM) and spleen stiffness measurement (SSM) using acoustic palpation elastography (APE) in patients with chronic hepatitis B (CHB). Methods A total of 392 patients with CHB were encountered in our hospital between January 2020 and October 2021, and all underwent liver biopsies. The LF was defined by METAVIR's score, and was divided into non-significant (less than F1) and significant (equal to or greater than F2). The LSM and SSM were obtained by using APE. The aspartate aminotransferase to platelet ratio index (APRI), FIB-4 and King's score were calculated. The diagnostic efficacy was evaluated by the the area under receiver operating characteristic curve (AUC). Results Out of the 392 patients with CHB, the histopathological examination showed F0 in 45 cases, F1 in 112 cases (non-significant LF in 157 cases), F2 in 105 cases, F3 in 70 cases and F4 (early cirrhosis) in 60 cases (significant LF in 235 cases); the LSM, SSM, APRI, FIB-4 and King's score in patients with significant LF were (13.4±2.0)kPa, (23.3±4.0)kPa,(2.2±0.4), (1.8±0.4) and (23.4±7.9), significantly greater than [(9.3±1.7)kPa, (15.0±3.6)kPa, (1.0±0.2), (0.9±0.2) and (10.4±6.9), respectively, P<0.05] in patients with non-significant LF; the multivariate Logistic regression analysis showed that the LSM, SSM, APRI, FIB-4 and King's score were all the independent factors impacting LF in patients with CHB (P<0.05); the sensitivity, specificity and accuracy of LSM and SSM combination in predicting significant LF were 79.6%, 83.0% and 81.6%, and in predicting early liver cirrhosis were 92.8%, 90.0% and 92.3%. Conclusion The application LSM and SSM by using APE in predicting the degree of liver fibrosis in patients with CHB is efficacious , which is worthy of further clinical investigation.

Key words: Hepatitis B, Liver fibrosis, Acoustic palpation elastography, Liver stiffness measurement, Spleen stiffness measurement, Diagnosis

杨艳, 刘婷, 戴琳, 努丽曼姑·麦麦提, 刘环. 声触诊弹性成像检测肝脾硬度诊断慢性乙型肝炎患者肝纤维化效能分析^*[J]. 实用肝脏病杂志, 2022, 25(2): 183-186.

Yang Yan, Liu Ting, Dai Lin, et al. Noninvasive assessment of liver fibrosis via liver and spleen stiffness measurement using acoustic palpation elastography in patients with chronic hepatitis B[J]. Journal of Practical Hepatology, 2022, 25(2): 183-186.

参考文献

[1] Zheng Y, Wu J, Ding C, et al. Disease burdenof chronic hepatitis B and complications in China from 2006 to 2050: an individual-based modeling study. Virol J, 2020, 17(1):132.
[2] Zhang YR, Wu DM, Liu XC, et al. Multimodal therapy and twenty years of valid management of a patient with chronic hepatitis B in a less developed region in China-case report and review of the literature. BMC Infect Dis, 2019, 19(1):49.
[3] Lei S, Chen S, Zhao X, et al. Hepatitis B virus infection and diabetes mellitus: the Kailuan prospective cohort study in China. Hepatol Int, 2020, 14(5):743-753.
[4] Li G, Wang G, Hsu FC, et al. Effects of depression, anxiety, stigma, and disclosure on health-related quality of life among chronic hepatitis B patients in Dalian, China. Am J Trop Med Hyg, 2020, 102(5):988-994.
[5] Xu C, Chen J, Zhang PA. Relationship between diabetes mellitus and cirrhosis risk in chronic hepatitis B patients in Wuhan, China. Med Sci Monit, 2019, 25:8112-8119.
[6] Si J, Yu C, Guo Y, et al. Chronic hepatitis B virus infection and total and cause-specific mortality: a prospective cohort study of 0.5 million people. BMJ Open, 2019, 9(4):e027696.
[7] Wang K, Lu X, Zhou H, et al. Deep learning radiomics of shear wave elastography significantly improved diagnostic performance for assessing liver fibrosis in chronic hepatitis B: a prospective multicentre study. Gut, 2019, 68(4):729-741.
[8] Xiao H, Shi M, Xie Y, Chi X. Comparison of diagnostic accuracy of magnetic resonance elastography and Fibroscan for detecting liver fibrosis in chronic hepatitis B patients: A systematic review and meta-analysis. PLoS One, 2017, 12(11):e0186660.
[9] Dong B, Huang S, Chang J, et al. Comparison of sound touch eastography, sound touch quantify, and 4 serum fibrosis indexes for the diagnosis of liver fibrosis in patients with chronic hepatitis B. Ultrasound Q, 2021, 37(2):123-128.
[10] Yang L, Li J, Ma L, et al. Noninvasive assessment of liver fibrosis in chronic hepatitis B carriers with APE: study of surgical pathology specimens. Expert Rev Med Devices, 2020, 17(8):845-853.
[11] Dong BT, Huang S, Lyu GR, et al. Assessment of liver fibrosis with liver and spleen stiffness measured by APE, serum fibrosis markers in patients with chronic hepatitis B. J Dig Dis, 2021, 22(6):342-350.
[12] Wong GL, Kwok R, Chan HL, et al. Measuring spleen stiffness to predict varices in chronic hepatitis B cirrhotic patients with or without receiving non-selective beta-blockers. J Dig Dis, 2016, 17(8):538-546.
[13] Chen SH, Li YF, Lai HC, et al. Noninvasive assessment of liver fibrosis via spleen stiffness measurement using acoustic radiation force impulse sonoelastography in patients with chronic hepatitis B or C. J Viral Hepat, 2012, 19(9):654-663.
[14] Chen S, Huang H, Liu Y, et al. A multi-parametric prognostic model based on clinical features and serological markers predicts overall survival in non-small cell lung cancer patients with chronic hepatitis B viral infection. Cancer Cell Int, 2020, 20(1):555.
[15] Kim MN, Lee JH, Chon YE, et al. Fibrosis-4, aspartate transaminase-to-platelet ratio index, and gamma-glutamyl transpeptidase-to-platelet ratio for risk assessment of hepatocellular carcinoma in chronic hepatitis B patients: comparison with liver biopsy. Eur J Gastroenterol Hepatol, 2020, 32(3):433-439.
[16] 中华医学会感染病学会分会,中华医学会肝病学分会.慢性乙型肝炎防治指南(2019年版).实用肝脏病杂志,2020, 23(1):S9-S32.
[17] Xia S, Ren X, Ni Z, et al. A noninvasive method-shear-wave elastography compared with transient elastography in evaluation of liver fibrosis in patients with chronic hepatitis B. Ultrasound Q, 2019, 35(2):147-152.
[18] Leung VY, Shen J, Wong VW, et al. Quantitative elastography of liver fibrosis and spleen stiffness in chronic hepatitis B carriers: comparison of shear-wave elastography and transient elastography with liver biopsy correlation. Radiology, 2013, 269(3):910-918.
[19] Hu X, Xu X, Zhang Q, et al. Indirect prediction of liver fibrosis by quantitative measurement of spleen stiffness using the Fibroscan system. J Ultrasound Med, 2014, 33(1):73-81.
[20] Liu J, Li Y, Yang X, et al. Comparison of two-dimensional shear wave elastography with nine serum fibrosis indices to assess liver fibrosis in patientswith chronic hepatitis B: a prospective cohort study. Ultraschall Med, 2019, 40(2):237-246.

声触诊弹性成像检测肝脾硬度诊断慢性乙型肝炎患者肝纤维化效能分析^*

Noninvasive assessment of liver fibrosis via liver and spleen stiffness measurement using acoustic palpation elastography in patients with chronic hepatitis B

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	黄平, 曾霞, 张亚萍, 毛加丽. 肝静脉波形分型联合肝脏超声半定量评分对慢性乙型肝炎患者肝纤维化程度评估价值研究^*[J]. 实用肝脏病杂志, 2022, 25(2): 187-190.
[2]	李振, 宁姗姗, 郭影, 王甜甜, 李莉华, 叶美红, 宋源源. 慢性乙型肝炎患者肝组织LXRα和CYP7A1基因水平变化及其与肝组织炎症和纤维化程度的关系研究^*[J]. 实用肝脏病杂志, 2022, 25(2): 191-194.
[3]	曲颖, 蔡晓波, 张启迪, 陆伦根. 体检人群血清M2型抗线粒体抗体流行率调查^*[J]. 实用肝脏病杂志, 2022, 25(2): 203-206.
[4]	郑小勤, 徐辉, 李丽, 靳华, 汪晓军, 勾春燕. 家族聚集性原发性胆汁性肝硬化患者临床特征分析[J]. 实用肝脏病杂志, 2022, 25(2): 207-210.
[5]	刘松涛, 刘梅, 渠亚超, 李瑞利, 邵晨, 闾军. 4例原发性肝脏神经内分泌肿瘤临床分析及文献复习[J]. 实用肝脏病杂志, 2022, 25(2): 251-254.
[6]	何福亮, 马琳, 李悦榕, 王宇, 王民, 冯丽娟, 张冠华, 欧晓娟, 刘福全, 贾继东. 非肝硬化性门脉高压的临床诊断[J]. 实用肝脏病杂志, 2022, 25(1): 1-4.
[7]	陈靖, 朱月永. 无创诊断肝硬化门静脉高压症:血清标志物还是影像学检查？[J]. 实用肝脏病杂志, 2022, 25(1): 9-12.
[8]	郑淑颖, 郭欢欢, 程长浩, 冯珍珍. 索非布韦联合雷迪帕韦治疗慢性丙型肝炎患者疗效研究^*[J]. 实用肝脏病杂志, 2022, 25(1): 26-29.
[9]	叶超, 李文渊, 李磊, 陈思, 李未, 张开光. 一组不明原因的肝损害患者肝组织病理学诊断研究^*[J]. 实用肝脏病杂志, 2022, 25(1): 38-41.
[10]	李艳乐, 刘笑宇, 姚建宁, 王春峰, 张连峰, 张学秀. 乙型肝炎肝硬化并发肝性脑病患者血氨水平与认知障碍关系研究^*[J]. 实用肝脏病杂志, 2022, 25(1): 74-78.
[11]	谭玉英, 张鑫, 张娟子, 张山西. MRI联合血清GPC3水平鉴别肝脏结节性增生病灶临床应用价值研究^*[J]. 实用肝脏病杂志, 2022, 25(1): 88-91.
[12]	肖倩, 周展, 胡小丽. 肝细胞癌患者肝内病灶超声造影参数变化^*[J]. 实用肝脏病杂志, 2022, 25(1): 92-95.
[13]	陈俊光, 邓晓妃, 林树俊, 雷震. 急性化脓性胆囊炎患者超声影像学特点及其诊断价值^*[J]. 实用肝脏病杂志, 2022, 25(1): 116-119.
[14]	杨帆, 王健, 文智. CT检查对诊断胆囊腺肌症的效能分析^*[J]. 实用肝脏病杂志, 2022, 25(1): 140-143.
[15]	汤磊, 邹桂舟. 外科疾病导致的胆源性肝损伤诊治现状[J]. 实用肝脏病杂志, 2021, 24(6): 769-771.